Final ICH Q12 Post-Approval Changes Guideline Expected In November

Legal Impasse Likely To End, Established Conditions Sure To Be Clarified

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".